Aliskiren
Active substance: aliskiren hemifumarate
TABLET, FILM COATED · ALISKIREN HEMIFUMARATE 150 mg/1
United StatesActive
Marketing holder: Prasco Laboratories
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ALISKIREN HEMIFUMARATE · 150 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-65a8-7475-b02a-e976764bacf5,01a12090-8de7-73ed-a327-86177efdd6a4,01a12094-ddba-7c29-8345-bd8c52d424ce,01a12096-ec45-7be7-9e25-0da407f81a2b,01a12098-a238-7f62-ad87-126dab93ba8e;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 66993-141
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 66993-141 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 66993-141 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 66993-141 · Verified 2026-10-09 · open in source